If a patient with chronic viral hepatitis B or chronic viral hepatitis C has elevated glutathione and glutamic oxalacetic aminotransferase, the patient needs to have a blood test for hepatitis B DNA or hepatitis C RNA to see if the virus is replicating. If the patient indicates that the virus has replicated and there is a combination of elevated GLTA and GTA, or if there is significant liver fibrosis, then antiviral therapy is required, either oral medication or interferon injections. The duration of interferon injections is about 6-12 months. For patients with hepatitis B, antiviral medication should not be discontinued, as discontinuation will cause a rebound in viral replication and a dramatic increase in liver function. For patients with hepatitis C, oral medications or interferon injections may be considered. For normal people, if there is a mild elevation of glutamic aminotransferase and glutamic oxalacetic aminotransferase, the patient is considered to have recently consumed alcohol, or stayed up late, strained, and long-term medication, causing liver function damage and liver cell necrosis. For such cases, patients need to actively pay attention to more rest, do not drink alcohol and do not stay up late. In addition, appropriate medication to lower transaminases, such as bifenthrin drops, the patient’s liver function will be slowly reduced to normal.